These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 16896537)
1. Temporal variation in the expression of the p53 protein in proliferating and differentiating murine erythroleukaemia cells. Bodalina UM; Hammond KD; Gilbert DA Mol Cell Biochem; 2007 Jan; 294(1-2):155-62. PubMed ID: 16896537 [TBL] [Abstract][Full Text] [Related]
2. Temporal changes in the expression of protein phosphatase 1 and protein phosphatase 2A in proliferating and differentiating murine erythroleukaemia cells. Bodalina UM; Hammond KD; Gilbert DA Cell Biol Int; 2005 Apr; 29(4):287-99. PubMed ID: 15943952 [TBL] [Abstract][Full Text] [Related]
3. Rhythmic patterns in the expression of the ras oncogene in proliferating and differentiating erythroleukaemia cells. Hammond KD; Savage N; Littlewood M Cell Biol Int; 2000; 24(8):529-37. PubMed ID: 10924226 [TBL] [Abstract][Full Text] [Related]
4. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application. Marks PA; Rifkind RA Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266 [TBL] [Abstract][Full Text] [Related]
5. High frequency oscillations in the activity of phosphotyrosine phosphatase in murine erythroleukaemic cells: action of insulin and hexamethylene bisacetamide. Ferreira GM; Wölfle H; Hammond KD; Gilbert DA Cell Biol Int; 1996 Sep; 20(9):599-605. PubMed ID: 8948121 [TBL] [Abstract][Full Text] [Related]
6. [Effects of hexamethylene bisacetamide on P53 protein expression of MEC-1 cell line and cell differentiation]. Liu B; Situ Z; Wu J; Chen J Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 Feb; 17(1):17-9. PubMed ID: 12539312 [TBL] [Abstract][Full Text] [Related]
7. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC. Marks PA; Michaeli J; Jackson J; Richon VM; Rifkind RA Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574 [TBL] [Abstract][Full Text] [Related]
8. Hexamethylene bisacetamide-induced differentiation of Friend virus-transformed murine erythroleukemia cells is associated with parallel changes in casein kinase II and guanine nucleotide exchange factor activities. Aroor AR; Singh LP; Wahba AJ Exp Hematol; 1995 Oct; 23(11):1204-11. PubMed ID: 7556531 [TBL] [Abstract][Full Text] [Related]
9. Protein kinase c in erythroleukaemia cells: temporal variations in the expression of the alpha, epsilon and zeta isoforms. Hammond KD; Savage N; Littlewood M Cell Biol Int; 2000; 24(8):549-57. PubMed ID: 10924228 [TBL] [Abstract][Full Text] [Related]
10. Changes in E2F DNA-binding activity during induced erythroid differentiation. Richon VM; Venta-Perez G Cell Growth Differ; 1996 Jan; 7(1):31-42. PubMed ID: 8788031 [TBL] [Abstract][Full Text] [Related]
11. Alterations in electrophoretic mobility, diaphorase activity, and terminal differentiation induced in murine erythroleukemia lines by differentiating agents. Gascoyne PR; Becker FF J Cell Physiol; 1990 Feb; 142(2):309-15. PubMed ID: 2303526 [TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of erythroid differentiation induced by hexamethylene bisacetamide in murine erythroleukemia cells. Petrak J; Myslivcova D; Man P; Cmejlova J; Cmejla R; Vyoral D Exp Hematol; 2007 Feb; 35(2):193-202. PubMed ID: 17258068 [TBL] [Abstract][Full Text] [Related]
13. Extracellular high-mobility group 1 protein is essential for murine erythroleukaemia cell differentiation. Sparatore B; Passalacqua M; Patrone M; Melloni E; Pontremoli S Biochem J; 1996 Nov; 320 ( Pt 1)(Pt 1):253-6. PubMed ID: 8947495 [TBL] [Abstract][Full Text] [Related]
14. Temporal changes in phosphoamino acid phosphatase activities in murine erythroleukaemic cells. Hammond KD; Cloutman L; Mindel B; Gilbert DA Int J Biochem; 1989; 21(2):197-201. PubMed ID: 2545474 [TBL] [Abstract][Full Text] [Related]
15. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation. Marks PA; Ramsay R; Sheffery M; Rifkind RA Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077 [TBL] [Abstract][Full Text] [Related]
16. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells. Chen J; Kremer CS; Bender TP Oncogene; 2006 May; 25(19):2758-72. PubMed ID: 16407849 [TBL] [Abstract][Full Text] [Related]
17. Electrophoretic forms of protein kinases during differentiation of murine erythroleukaemic cells. Hammond KD; Sprott S; Savage N Anticancer Res; 1987; 7(3 Pt B):521-5. PubMed ID: 2820295 [TBL] [Abstract][Full Text] [Related]
18. Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation. Richon VM; Ramsay RG; Rifkind RA; Marks PA Oncogene; 1989 Feb; 4(2):165-73. PubMed ID: 2648254 [TBL] [Abstract][Full Text] [Related]
19. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage. Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822 [TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis by hexamethylene bisacetamide is p53-dependent associated with telomerase activity but not with terminal differentiation. Zhang Z; Liong EC; Lau TY; Leung KM; Fung PC; Tipoe GL Int J Oncol; 2000 May; 16(5):887-92. PubMed ID: 10762623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]